Atopic Dermatitis — The Skin Manifestation of Atopy

Conference paper

Abstract

Atopic dermatitis represents an inflammatory skin disorder which has been well known since the beginning of the century [57]. The manifestations of the disease have attracted the interest of many biomedical disciplines. The management of the patients, however, is still a challenge. Even in 1994 conventional treatment remains the therapeutic basis. As late as 1980, diagnostic guidelines delineating clinical populations for investigative studies were first established [19].

Keywords

Nickel Dust Interferon Histamine Psoriasis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baggiolini M, Dahinden CA (1994) CC chemokines in allergic inflammation. Immunol Today 15: 127–133PubMedCrossRefGoogle Scholar
  2. 2.
    Barnetson RStC, MacFarlane HAF, Benton EC (1987) House dust mite allergy and atopic eczema: a case report. Br J Dermatol 116: 857–860PubMedCrossRefGoogle Scholar
  3. 3.
    Bieber T, Dannenberg B, Prinz JC, Rieber EP, Stolz W, Braun-Falco O (1989) Occurrence of IgE-bearing Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the serum IgE level. J Invest Dermatol 93: 215–219PubMedCrossRefGoogle Scholar
  4. 4.
    Bieber T, de la Salle H, Wollenberg A, Hakimi J, Chizzontie R, Ring J, Hanau D, de la Salle C (1992) Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 175: 1285–1290Google Scholar
  5. 5.
    Bousquet J, Chanez P, Lacoste JY, Baméon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel F-B (1990) Eosinophilic inflammation in asthma. N Engl J Med 323: 1033–1039PubMedCrossRefGoogle Scholar
  6. 6.
    Bruijnzeel PL, Bruijnzeel-Koomen CA (1989) Skin eosinophilia in atopic dermatitis. Allerg Immunol (Paris) 21: 224–2275Google Scholar
  7. 7.
    Bruijnzeel PLB, Kuijper PHM, Kapp A, Warringa RAJ, Betz S, Bruijnzeel-Koomen CAFM (1993) The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis. Clin Exp Allergy 23: 97–109PubMedCrossRefGoogle Scholar
  8. 8.
    Bruijnzeel-Koomen CA, van Wichen DF, Spry CJ, Venge P, Bruijnzeel PL (1988) Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 118: 229–2387CrossRefGoogle Scholar
  9. 9.
    Burges GE, Lang PG (1987) Atopic dermatitis exacerbated by inhalant allergens. Arch Dermatol 123: 1437–1438PubMedCrossRefGoogle Scholar
  10. 10.
    Chandra RK, Baker M (1983) Numerical and functional deficiency of suppressor T cells preceeds development of atopic eczema. Lancet II: 1393–1394CrossRefGoogle Scholar
  11. 11.
    Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM (1989) Cutaneous late-phase response to allergen. J Clin Invest 83: 1519–1526PubMedCrossRefGoogle Scholar
  12. 12.
    Coleman R, Trembath RC, Harper JI (1993) Chromosome 11813 and atopy underlying atopic eczema. Lancet 341: 1121–1122PubMedCrossRefGoogle Scholar
  13. 13.
    Colver GB, Symons JA, Duff GW (1989) Soluble interleukin 2 receptor in atopic eczema. BMJ 298: 1426–1428PubMedCrossRefGoogle Scholar
  14. 14.
    Czech W, Krutmann J, Schöpf E, Kapp A (1992) Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 126: 351–355PubMedCrossRefGoogle Scholar
  15. Dvorak AM, Ackerman SJ, Weller PF (1990) Subcellular morphology and biochemistry of eosinophils. In: Harris JR (ed) Blood cell biochemistry, vol 2: megakaryocytes, platelets, macrophages, and eosinophils. Plenum, New York, pp 237–344Google Scholar
  16. 16.
    Galli SJ, Gordon JR, Wershil BK (1993) Mast cell cytokines in allergy and inflammation. Agents Actions 43: 209–220Google Scholar
  17. 17.
    Gondo A, Saeki N, Tokuda Y (1986) Challenge reactions in atopic dermatitis after percutaneous entry of mite antigen. Br J Dermatol 115: 485–493PubMedCrossRefGoogle Scholar
  18. 18.
    Grewe M, Gyufko K, Schöpf E, Krutmann J (1994) Lesional expression of interferon-y in atopic eczema. Lancet 343: 25–26PubMedCrossRefGoogle Scholar
  19. 19.
    Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92: 44–47Google Scholar
  20. 20.
    Jakob T, Hermann K, Ring J (1991) Eosinophil cationic protein in atopic eczema. Arch Dermatol Res 283: 5–6PubMedCrossRefGoogle Scholar
  21. 21.
    Jujo K, Renz H, Abe J, Gelfand EW, Leung DY (1992) Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 90: 323–331PubMedCrossRefGoogle Scholar
  22. 22.
    Kaegi MK, Joller-Jemelka H, Wüthrich B (1992) Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 185: 88–92CrossRefGoogle Scholar
  23. 23.
    Kapp A (1991) Cytokines in atopic dermatitis. In: Ruzicka T, Ring J, Przybilla B (eds) Handbook of atopic eczema. Springer, Berlin Heidelberg New York, pp 256–262Google Scholar
  24. 24.
    Kapp A (1993) The role of eosinophils in the pathogenesis of atopic dermatitis — eosinophil granule proteins as markers of disease activity. Allergy 48: 1–5PubMedCrossRefGoogle Scholar
  25. 25.
    Kapp A, Czech W, Krutmann J, Schöpf E (1991) Eosinophil cationic protein (ECP) in sera of patients with atopic dermatitis. J Am Acad Dermatol 24: 555–558PubMedCrossRefGoogle Scholar
  26. 26.
    Kapp A, Gillitzer R, Kirchner H, Schöpf E (1987) Production of interferon and lymphoproliferative responses in whole blood cultures derived from patients with atopic dermatitis. Arch Dermatol Res 279: S55 - S58PubMedCrossRefGoogle Scholar
  27. 27.
    Kapp A, Gillitzer R, Kirchner H, Schöpf E (1988) Decreased production of interferon in whole blood cultures derived from patients with psoriasis. J Invest Dermatol 90: 511–514PubMedCrossRefGoogle Scholar
  28. 28.
    Kapp A, Kemper A, Schöpf E, Deicher H (1986) Detection of circulating immune complexes in patients with atopic dermatitis and psoriasis. Acta Derm Venereol (Stockh) 66: 121–126Google Scholar
  29. 29.
    Kapp A, Kirnbauer R, Luger TA, Schöpf E (1987) Altered production of immunomodulating cytokines in patients with atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 144: 97–99Google Scholar
  30. 30.
    Kapp A, Löbig K-P, Schöpf E (1989) Allergie gegen Vorratsmilben bei Patienten mit atopischer Dermatitis — eine RAST Studie. Allergologie 12: 315–317Google Scholar
  31. 31.
    Kapp A, Neuner P, Krutmann J, Luger TA, Schöpf E (1991) Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis — comparison with serum interleukin-2 receptor levels. Acta Derm Venereol (Stockh) 71: 403–406Google Scholar
  32. 32.
    Kapp A, Piskorski A, Schöpf E (1988) Elevated levels of interleukin-2 receptor in sera of patients with atopic dermatitis and psoriasis. Br J Dermatol 119: 707–710PubMedCrossRefGoogle Scholar
  33. 33.
    Kapp A, Schöpf E (1986) Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis. Acta Derm Venerol (Stockh) 66: 285–289Google Scholar
  34. 34.
    Kapp A, Schöpf E (1989) Spezifisches IgE gegen Staphylokokkus aureus bei Patienten mit Atopischer Dermatitis. Hautarzt 40: 19–22PubMedGoogle Scholar
  35. 35.
    Kapp A, Textor A, Krutmann J, Möller A (1990) Immuno-modulating cytokines in atopic dermatitis and psoriasis — production of tumor necrosis factor/ cachectin and lymphotoxin by mononuclear cells in vitro. Br J Dermatol 122: 587–592PubMedCrossRefGoogle Scholar
  36. 36.
    Kapp A, Wokalek H, Schöpf E (1985) Involvement of complement in psoriasis and atopic dermatitis — measurement of C3a and C5a, C3, C4 and Cl inactivator. Arch Derm Res 277: 359–361PubMedCrossRefGoogle Scholar
  37. 37.
    Kapp A, Zeck-Kapp G (1991) Interleukin-5 induced granulocyte activation in atopic patients. Br J Dermatol 125: 108–115PubMedCrossRefGoogle Scholar
  38. 37.
    Kapp A, Zeck-Kapp G (1991) Interleukin-5 induced granulocyte activation in atopic patients. Br J Dermatol 125: 108–115PubMedCrossRefGoogle Scholar
  39. 39.
    Kapsenberg ML, Wierenga EA, Stiekma FE, Tiggelman AM, Bos JD (1992) Thi lymphokine production profiles of nickel-specific CD4+T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 98: 59–63PubMedCrossRefGoogle Scholar
  40. 40.
    Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E (1992) Highdose-UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26: 225–230PubMedCrossRefGoogle Scholar
  41. 41.
    Leiferman KM (1989) Eosinophils in atopic dermatitis. Allergy 44 [Suppl 9]: 20–26PubMedGoogle Scholar
  42. 42.
    Leiferman KM (1991) A current perspective on the role of eosinophils in dermatologic diseases. J Am Acad Dermatol 24: 1101–1112PubMedCrossRefGoogle Scholar
  43. 43.
    Leiferman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencie PY, Gleich GJ (1985) Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 313: 282–285PubMedCrossRefGoogle Scholar
  44. 44.
    Leung DY, Geha RS (1986) Immunoregulatory abnormalities in atopic dermatitis. Clin Rev Allergy 4: 67–86PubMedGoogle Scholar
  45. 45.
    Leung DYM (1992) Immunopathology of atopic dermatitis. Springer Semin Immunopathol 13: 427–440PubMedCrossRefGoogle Scholar
  46. 46.
    Lever R, Turbitt M, Sanderson A, MacKie R (1987) Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 89: 4–7PubMedCrossRefGoogle Scholar
  47. 47.
    Lever RS, Lesko MJ, MacKie RM, Parrott DM (1985) Natural killer cell activity in atopic dermatitis: a sequential study. Clin Allergy 15: 479–486PubMedCrossRefGoogle Scholar
  48. 48.
    Maeda K, Yamamoto K, Tanaka Y, Anan S, Yoshida H (1992) The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitis. J Dermatol Sci 3: 151–156PubMedCrossRefGoogle Scholar
  49. 49.
    Morita E, Schröder JM, Christophers E (1989) Chemotactic responsiveness of eosinophils isolated from patients with inflammatory skin diseases. J Dermatol (Tokyo) 16: 348–351Google Scholar
  50. 50.
    Moser R, Fehr J, Bruijnzeel PLB (1992) IL-4 controls the selective endothelium driven transmigration of eosinophils from allergic individuals. J Immunol 149: 1432–1438PubMedGoogle Scholar
  51. 51.
    Mudde GC, van Reijsen FC, Boland GJ, de Gast GC, Bruijnzeel PLB, Bruijnzeel CAFM (1990) Allergen presentation by epidermal Langerhans’ cells from patients with atopic dermatitis is mediated by IgE. Immunology 69: 335–341PubMedGoogle Scholar
  52. 52.
    Mudde GC, van Reijsen FC, Bruijnezeel-Koomen CA (1992) IgE-positive Langerhans cells and Th2 allergen-specific T cells in atopic dermatitis. J Invest Dermatol 99: 103SGoogle Scholar
  53. 53.
    Neuner P, Urbanski A, Trautinger F, Möller A, Kirnbauer R, Kapp A, Schöpf E, Schwarz T, Luger TA (1991) Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis. J Invest Dermatol 97: 27–33PubMedCrossRefGoogle Scholar
  54. 54.
    Norris PG, Schofield O, Camp RDR (1988) A study of house dust mite in atopic dermatitis. Br J Dermatol 1988: 118: 435–440CrossRefGoogle Scholar
  55. 55.
    Paganelli R, Fanales-Belasio E, Carmini D, Scala E, Meglio P, Businco L, Aiuti F (1991) Serum eosinophil cationic protein in patients with atopic dermatitis. Int Arch Allergy Appl Immunol 96: 175–178PubMedCrossRefGoogle Scholar
  56. 56.
    Peterson CGB, Jörnvall H, Venge P (1988) Purification and characterization of eosinophil cationic protein from normal human eosinophils. Eur J Haematol 40: 415–423PubMedCrossRefGoogle Scholar
  57. 57.
    Rajka, G (1990) Essential aspects of atopic eczema. Springer, Berlin Heidelberg New YorkGoogle Scholar
  58. 58.
    Räsanen L, Lehto M, Reunala T, Jansen C, Leinikki P (1987) Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis. Arch Dermatol Res 279: 215–218PubMedCrossRefGoogle Scholar
  59. 59.
    Ramb-Lindhauer C, Feldmann A, Rotte M, Neumann C (1991) Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin. Arch Dermatol Res 283: 71–76PubMedCrossRefGoogle Scholar
  60. 60.
    Reinhold U, Wehrmann W, Kukel S, Kreysel HW (1990) Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol 79: 374–379PubMedCrossRefGoogle Scholar
  61. 61.
    Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel HW (1991) Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 86: 444–448PubMedCrossRefGoogle Scholar
  62. 62.
    Reitamo S, Visa K, Kähönen K, Käyhkö K, Stubb S, Salo OP (1986) Eczematous reactions in atopic dermatitis caused by epicutaneous testing with inhalant allergens. Br J Dermatol 114: 303–309PubMedCrossRefGoogle Scholar
  63. 63.
    Renz H, Jujo K, Bradley KL, Domenico J, Gelfand EW, Leung DY (1992) Enhanced ‘IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 99: 403–408PubMedCrossRefGoogle Scholar
  64. 64.
    Rieger A, Wang B, Kilgus O, Ochiai K, Maurer D, Fodinger D, Kinet JP, Stingl G (1992) Fc epsilon RI mediates IgE binding to human epidermal Langerhans cells. J Invest Dermatol 99: 30S–32SPubMedCrossRefGoogle Scholar
  65. 65.
    Rocha C, de Maubeuge J, Sarfati M, Song M, Delespesse G (1984) Characterization of cellular inifiltrates in skin lesions of atopic eczema. Dermatologica 169: 330–338PubMedCrossRefGoogle Scholar
  66. 66.
    Rogge JL, Hanifin JM (1976) Immunodeficiencies in severe atopic dermatitis. Arch Dermatol 112: 1391–1396PubMedCrossRefGoogle Scholar
  67. 67.
    Romagnani S (1992) Human Thl and Th2 subsets: regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98: 279–285PubMedCrossRefGoogle Scholar
  68. 68.
    Romagnani S, Del Prete GF, Maggi E, Ricci M (1993) Thl and Th2 cells and their role in disease. ACI News 5: 19–22Google Scholar
  69. 69.
    Ruiz RG, Kemeny DM, Price JF (1992) Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy. Clin Exp Allergy 22: 762–766PubMedCrossRefGoogle Scholar
  70. 70.
    Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C (1992) House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 89: 801–810PubMedCrossRefGoogle Scholar
  71. 71.
    Schöpf E, Kapp A, Kim CW (1978) T-Cell function in atopic dermatitis — controlled examination of concanavalin A dose-response relations in cultured lymphocytes. Arch Dermatol Res 262: 37–44PubMedCrossRefGoogle Scholar
  72. 72.
    Schultz Larsen FS, Holm NV, Hennigsen K (1986) Atopic dermatitis. A geneticepidemiologic study in a population-based twin sample. J Am Acad Dermatol 15: 487–494CrossRefGoogle Scholar
  73. 73.
    Schultz Larsen F (1993) Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 28: 719–723PubMedCrossRefGoogle Scholar
  74. 74.
    Soter NA (1989) Morphology of atopic eczema. Allergy 44 [Suppl 9]: 16–19PubMedGoogle Scholar
  75. 75.
    Sugai T, Sakiyama Y, Matumoto S (1992) Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases. Clin Exp Allergy 22: 275–281PubMedCrossRefGoogle Scholar
  76. 76.
    Tanaka Y, Anan S, Yoshida H (1990) Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J Dermatol Sci 1: 361–368PubMedCrossRefGoogle Scholar
  77. 77.
    Thestrup-Pedersen K, Schade Larsen C, Kristense M, Zachariae C (1990) Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis. Acta Derm Venerol (Stockh) 70: 395–399Google Scholar
  78. 78.
    Tsuda S, Kato K, Miyasato M, Sasai Y (1992) Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein. J Dermatol (Tokyo) 19: 208–213Google Scholar
  79. 79.
    Tuft L (1949) Importance of inhalant allergens in atopic dermatitis. J Invest Dermatol 12: 211–219PubMedGoogle Scholar
  80. 80.
    Uehara M, Izukura R, Sawai T (1990) Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 1990: 15: 264–266CrossRefGoogle Scholar
  81. 81.
    van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg ML (1991) High frequency of IL-4-producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 97: 389–394PubMedCrossRefGoogle Scholar
  82. 82.
    van Reijsen FC, Bruijnezeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, Mudde GC (1992) Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90: 184–193PubMedCrossRefGoogle Scholar
  83. 83.
    Venge P (1994) Soluble markers of allergic inflammation. Allergy 49: 1–8PubMedCrossRefGoogle Scholar
  84. 84.
    Venge P, Dahl R, Fredens K, Hällgren R, Peterson CGB (1983) Eosinophil cationic proteins (ECP and EPX) in health and disease. In: Yoshida T, Torisu M (eds) Immunobiology of the eosinophil. Elsevier Biomedical, New York, pp 163–179Google Scholar
  85. 85.
    Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, Kinet JP, Stingl G (1992) Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. J Exp Med 175: 1353–1365PubMedCrossRefGoogle Scholar
  86. 86.
    Weller PF (1991) The immunobiology of eosinophils. N Engl J Med 324: 1110–1118PubMedCrossRefGoogle Scholar
  87. 87.
    Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, Kapsenberg ML (1990) Evidence for compartmentalization of functional subsets of CD3+ T lymphocytes in atopic patients. J Immunol 144: 4651–4655PubMedGoogle Scholar
  88. 88.
    Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RA, Kapsenberg ML (1991) Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 147: 2942–2949PubMedGoogle Scholar
  89. 89.
    Wüthrich B, Joller-Jemelka H, Helfenstein U, Grob PJ (1990) Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis. Dermatologica 181: 92–97PubMedCrossRefGoogle Scholar
  90. 90.
    Zachary CB, Allen MH, MacDonald DM (1985) In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 112: 149–156PubMedCrossRefGoogle Scholar
  91. 91.
    Zachary CB, MacDonald DM (1983) Quantitative analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytofluorimetry. Br J Dermatol 108: 411–422PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • A. Kapp

There are no affiliations available

Personalised recommendations